^
Association details:
Biomarker:No biomarker
Cancer:Gallbladder Cancer
Regimen:GEM-CAP (capecitabine + gemcitabine)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Neoadjuvant therapy (for gallbladder cancer only)…Other recommended regimens…Gemcitabine + capecitabine